biotechnology research and development

Celdara Medical transforms academic innovations into medicines, partnering with inventors and research institutions in the US, EU, and beyond. It provides developmental, financial, and business acumen to bridge discovery and clinical impact, building academic and early-stage innovations into high-potential biotechnology companies.

Read more

preclinical and clinical strategyregulatory strategyrisk managementseed funding

Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in a virtual mode that is pursuing biologically-based, disease-modifying therapeutic solutions for neurodegenerative disorders known as tauopathies, including Alzheimer's disease, frontotemporal dementia, chronic traumatic encephalopathy, progressive supranuclear palsy, and corticobasal degeneration. INT is advancing monoclonal antibody candidates against key epitopes of Tau toward Phase I clinical trials as prospective passive immunotherapies.

Read more

monoclonal antibody developmentrecombinant AAV vector developmenttherapeutic development for tauopathies